Suraksha Diagnostic IPO Day 3 : GMP, Price Band, Subscription, Key Dates and (...)
Suraksha Diagnostic's IPO was fully subscribed on the final day despite initial lukewarm interest. This was due to its offer-for-sale structure, meaning proceeds will not go to the company but to selling shareholders. Most analysts recommended avoiding the IPO due to its high valuation and (...)
Site référencé: The Economic Times
The Economic Times
Jefferies upgrades Swiggy to buy with Rs 500 target price but calls it high risk-high reward play
1er/08/2025
Bridgewater founder Ray Dalio sells remaining stake in hedge fund
1er/08/2025
Jonathan Schiessl sees limited impact on India from US tariff moves
1er/08/2025
The Golden Thumb Rule : Medical inflation is a silent threat—PGIM India’s Ajit Menon urges investors to plan proactively
1er/08/2025
Ashish Kacholia-backed Shree Refrigerations shares list at 36% premium over IPO price on BSE SME platform
1er/08/2025
Dollar strong as Trump imposes new tariff rates ; yen sinks to four-month low
1er/08/2025
